Rikiya Nakamura

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

Breast Oncology, Overall Survival, Medicine +7

Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis

Naoki Niikura, Naoki Hayashi, Norikazu Masuda et al. · Breast Cancer Research and Treatment · 2014 · 195 citations

Neuro-oncology, Breast Oncology, Brain Metastases +7

PALOMA-3: Phase III Trial of Fulvestrant With or Without Palbociclib in Premenopausal and Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That Progressed on Prior Endocrine Therapy—Safety and Efficacy in Asian Patients

Hiroji Iwata, Seock‐Ah Im, Norikazu Masuda et al. · Journal of Global Oncology · 2017 · 125 citations · Full text

Early Detection of Lymphatic Disorder and Treatment for Lymphedema following Breast Cancer

Shinsuke Akita, Rikiya Nakamura, Naohito Yamamoto et al. · Plastic & Reconstructive Surgery · 2016 · 123 citations

Imlunestrant with or without Abemaciclib in Advanced Breast Cancer

Komal Jhaveri, Patrick Neven, M.L. Casalnuovo et al. · New England Journal of Medicine · 2024 · 109 citations